EMT was considered as a major reason for tumor mobility which was characterized by down-regulation of epithelial markers (e.g., E-cadherin) and up-regulation of mesenchymal markers (e.g., Vimentin and N-cadherin) (29). The gene discussed is CDH2; the disease is neoplasm.